Royalty Pharma's total assets for Q1 2025 were $17.61B, a decrease of -3.37% from the previous quarter. RPRX total liabilities were $7.82B for the fiscal quarter, a -0.77% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.